✦ LIBER ✦

Tolerability of Human Immunoglobulin 10% Administered Subcutaneously Following Administration of Recombinant Human Hyaluronidase (rHuPH20) in Primary Immunodeficiency Disease (PIDD) Patients

✍ Scribed by Gelmont, D.; Wasserman, R.L.; Melamed, I.; Stein, M.; Rubinstein, A.; McCoy, B.; Engl, W.; Leibl, H.; Schiff, R.I.; Grossman, W.J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics (PK) of Human Immunoglo

✍ Rubinstein, A.; Wasserman, R.L.; Melamed, I.; Stein, M.; McCoy, B.; Engl, W.; Le 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Pharmacokinetics (PK) of Human Immunoglo

✍ Stein, M.; Wasserman, R.L.; Melamed, I.; Puck, J.; Gupta, S.; Engl, W.; Leibl, H 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Effects of Recombinant Human Hyaluronida

✍ Bee, W.H.; Nekoroski, T.; Zhang, L.; Kang, D.; Teschner, W.; Schwarz, H.P.; Much 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Tolerability and Efficacy of Facilitated

✍ Wasserman, R.L.; Melamed, I.; Stein, M.; Puck, J.; Gupta, S.; Engl, W.; Leibl, H 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Efficacy Analysis of Immune Globulin Sub

✍ Schiff, R.I.; Wasserman, R.L.; Melamed, I.; Stein, M.; Engl, W.; Leibl, H.; Gelm 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Pharmacokinetic Analysis (PK) of Immune

✍ Leibl, H.; Wasserman, R.L.; Melamed, I.; Stein, M.; Engl, W.; Schiff, R.I.; Gelm 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB